RU2003107768A - TREATMENT MEMBRANE-CONTROLLED BANDAGE - Google Patents

TREATMENT MEMBRANE-CONTROLLED BANDAGE

Info

Publication number
RU2003107768A
RU2003107768A RU2003107768/14A RU2003107768A RU2003107768A RU 2003107768 A RU2003107768 A RU 2003107768A RU 2003107768/14 A RU2003107768/14 A RU 2003107768/14A RU 2003107768 A RU2003107768 A RU 2003107768A RU 2003107768 A RU2003107768 A RU 2003107768A
Authority
RU
Russia
Prior art keywords
controlled
bandage
membrane
treatment membrane
molecular weight
Prior art date
Application number
RU2003107768/14A
Other languages
Russian (ru)
Other versions
RU2233674C1 (en
Inventor
Юрий Семенович Винник
Сергей Владимирович Якимов
Геворк Эдуардович Карапетян
Георгий Михайлович Сычев
Игорь Николаевич Большаков
Original Assignee
Красноярская государственная медицинская академия
Filing date
Publication date
Application filed by Красноярская государственная медицинская академия filed Critical Красноярская государственная медицинская академия
Priority to RU2003107768/14A priority Critical patent/RU2233674C1/en
Priority claimed from RU2003107768/14A external-priority patent/RU2233674C1/en
Application granted granted Critical
Publication of RU2233674C1 publication Critical patent/RU2233674C1/en
Publication of RU2003107768A publication Critical patent/RU2003107768A/en

Links

Claims (1)

Лечебная мембранно-контролируемая повязка, включающая замкнутую полость со стенками из полупроницаемой мембраны, заполненную гелем и лекарственными веществами, отличающаяся тем, что в качестве полупроницаемой мембраны используют трубчатую ацетат-целлюлозную мембрану фирмы Sigma с наружным диаметром 2,7 см, имеющей диаметр пор 2,5-2,8 нм, пропускающих вещества до 10000 Д, содержащую ксерогель органической соли хитозана с молекулярной массой 10000 Д, и лекарственный состав включает медикаменты молекулярной массой до 5000 Д.Therapeutic membrane-controlled dressing, including a closed cavity with walls of a semipermeable membrane, filled with gel and medicinal substances, characterized in that as a semipermeable membrane using a tubular acetate-cellulose membrane company Sigma with an outer diameter of 2.7 cm, having a pore diameter of 2, 5-2.8 nm, passing substances up to 10,000 D, containing the xerogel of an organic salt of chitosan with a molecular weight of 10,000 D, and the pharmaceutical composition includes medicines with a molecular weight of up to 5,000 D.
RU2003107768/14A 2003-03-20 2003-03-20 Membrane-controlled salve dressing RU2233674C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003107768/14A RU2233674C1 (en) 2003-03-20 2003-03-20 Membrane-controlled salve dressing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003107768/14A RU2233674C1 (en) 2003-03-20 2003-03-20 Membrane-controlled salve dressing

Publications (2)

Publication Number Publication Date
RU2233674C1 RU2233674C1 (en) 2004-08-10
RU2003107768A true RU2003107768A (en) 2004-09-10

Family

ID=33414156

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003107768/14A RU2233674C1 (en) 2003-03-20 2003-03-20 Membrane-controlled salve dressing

Country Status (1)

Country Link
RU (1) RU2233674C1 (en)

Similar Documents

Publication Publication Date Title
ES2553742T3 (en) Pharmaceutical dosage form comprising 6'-fluor- (N-methyl- or N, N-dimethyl) -4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane-1,1'-pyran [3,4, b] indole] -4-amine
RU2350333C3 (en) Application of ivermectin for the treatment of dermatologic disorders
NO2014028I2 (en) Glucopyranosyl-substituted benzene derivatives, process for their preparation, physiologically acceptable salts of such compounds, drugs containing such compounds and combinations with other active substances, and their use in the manufacture of drugs for the treatment of disease
WO2006048829A3 (en) Preparation of chitin and derivatives thereof for cosmetic and therapeutic use
BR112013003677A2 (en) use of pharmacologically active agent and pharmaceutical dosage form
ATE410424T1 (en) SPIROCYCLIC CYCLOHEXANE DERIVATIVES
EA200800798A1 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF DISTURBANCES OF THE INTERNAL EAR
ATE432919T1 (en) AZETIDINE DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE478840T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 3-AMINOAZETIDEDINE DERIVATIVES, THESE DERIVATIVES AND THE PRODUCTION THEREOF
ATE350377T1 (en) SUBSTITUTED 3-PYRROLIDINE INDOLE DERIVATIVES
AU2007211617A8 (en) Hydrogel
PA8594801A1 (en) PALANOSETRON LIQUID PHARMACEUTICAL FORMULATIONS
ATE412635T1 (en) DIPHENYLPYRIDINE DERIVATIVES, THEIR PRODUCTION AND THEIR THERAPEUTIC USE
DE60305037D1 (en) PIPERAZINYLACYLPIPERIDIN DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
NO20055601D0 (en) Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients
ZA200606679B (en) Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation
WO2005079750A3 (en) Films for use as dosage forms
ATE474840T1 (en) 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
RU2003107768A (en) TREATMENT MEMBRANE-CONTROLLED BANDAGE
EE200200551A (en) Pharmaceutical composition containing oligosaccharides, oligosaccharides, their preparation and therapeutic use
ES2602179T3 (en) A wound care device
RU2007116477A (en) METHOD FOR TREATMENT OF BACTERIAL PURULENT MENITITIS IN CHILDREN
ATE413171T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ASCORBIC ACID FOR THE TREATMENT OF FUNGAL SUPERINFECTIONS AND FUNGAL RECUPS
NL1022442C2 (en) Use of lipid to improve the absorption of nutrients and (pharmaceutically) active substances.
EA200701525A1 (en) PHARMACEUTICAL POLYMERIC COMPOSITION FOR ORAL ADMINISTRATION OF TERBUTALINE SULFATE WITH CONTROLLED DELIVERY